𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reduction of stress—A new therapeutic goal in the treatment of inflammatory bowel disease?

✍ Scribed by Viktor E. Eysselein

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
282 KB
Volume
6
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Italian registry of therapeutic aphe
The Italian registry of therapeutic apheresis: Granulocyte–monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study
✍ Stefano Passalacqua; Pietro Manuel Ferraro; Giampaolo Bresci; Valeria D'Ovidio; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views

## Abstract Leukocytes are thought to play an important role in the pathogenesis of inflammatory bowel diseases; granulocyte–monocyte adsorptive (GMA) apheresis, an extracorporeal technique aimed at removing activated circulating leukocytes from the blood, may represent a safe and effective therape

New players in the cytokine orchestra of
New players in the cytokine orchestra of inflammatory bowel disease
✍ Massimo C. Fantini; Giovanni Monteleone; Thomas T. MacDonald 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 2 views

In both Crohn's disease (CD) and ulcerative colitis, the pathologic process is almost certainly driven by an aberrant local immune response directed against normal components of the bacterial microflora. Mucosal immune cells interact with nonimmune cells such as epithelial cells and fibroblasts to p

Boosting the hypoxia-induced adaptive re
Boosting the hypoxia-induced adaptive response in inflammatory bowel disease: A novel concept of treatment
✍ Pieter Hindryckx; Debby Laukens; Martine De Vos 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB 👁 1 views

As cells critically depend on oxygen for function and survival, inadequate cellular oxygenation is a major factor in the pathogenesis of a number of life-threatening diseases. Not surprisingly, cells share adaptive mechanisms to protect them against low-oxygen conditions. The recent discovery of a n

Medium-term results of oral tacrolimus t
Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease
✍ Siew C. Ng; Naila Arebi; Michael A. Kamm 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Background: This study aimed to evaluate the efficacy of oral tacrolimus in patients with inflammatory bowel disease (ibd) refractory to conventional therapy, including azathioprine, 6-mercaptopurine, and infliximab. ## Methods: Retrospective review of all patients with ibd treated with oral t